Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Danaher Acquires Masimo in a $9.9B Telehealth Deal
Infrastructure & Management Danaher Acquires Masimo in a $9.9B Telehealth Deal

In a landmark transaction set to reshape the medical technology landscape, global life sciences conglomerate Danaher Corporation has officially announced its definitive agreement to acquire Masimo, a pioneer in advanced patient monitoring technologies. The all-cash deal, valued at a substantial

Does Your Radiology AI Actually Work Here?
Imaging & Diagnostics Does Your Radiology AI Actually Work Here?

The promise of artificial intelligence in radiology is immense, but many healthcare organizations are discovering a frustrating gap between an AI model's advertised performance and its actual effectiveness in their own clinical environment. This "performance drift" happens because an algorithm

Can AI In The EHR Revolutionize Patient Care?
Digital Health Can AI In The EHR Revolutionize Patient Care?

The modern clinical environment presents a significant paradox where physicians are surrounded by an unprecedented volume of data within the electronic health record, yet they often struggle to access the precise, evidence-based information needed at the moment of a critical decision. This deluge

Are Kidney Stone Scans Unnecessarily Risky?
Imaging & Diagnostics Are Kidney Stone Scans Unnecessarily Risky?

The intense, debilitating pain of a kidney stone often sends patients rushing to the emergency room, where the primary goal is a swift and accurate diagnosis to guide immediate treatment, but this urgent search for answers frequently involves a hidden, long-term risk. The go-to diagnostic tool, the

Could a Blood Test Revolutionize Alzheimer's Care?
Imaging & Diagnostics Could a Blood Test Revolutionize Alzheimer's Care?

For millions of families, the journey to an Alzheimer's diagnosis has long been a frustrating and arduous path paved with uncertainty, invasive procedures, and prolonged waiting periods for definitive answers. The traditional diagnostic toolkit, heavily reliant on expensive brain scans and

Could a Unified Platform Reshape Clinical Trials?
Imaging & Diagnostics Could a Unified Platform Reshape Clinical Trials?

The landscape of clinical research is currently navigating a complex and often fragmented technological terrain, where sponsors and contract research organizations (CROs) frequently juggle a patchwork of disparate systems to manage the lifecycle of a trial. This siloed approach creates significant

How Is AI Fueling Hinge Health's Dominance?
Digital Health How Is AI Fueling Hinge Health's Dominance?

In the rapidly evolving landscape of digital health, a company’s ability to scale operations without sacrificing quality of care has become the ultimate benchmark for success. Hinge Health, a prominent provider of digital musculoskeletal (MSK) care, is not just meeting this benchmark but redefining

AFib Symposium Spotlights New Ablation and Stroke Tech
Infrastructure & Management AFib Symposium Spotlights New Ablation and Stroke Tech

The recent 2026 Atrial Fibrillation Symposium in Boston served as a critical forum where the world’s leading cardiac device innovators showcased groundbreaking technologies, firmly establishing pulsed field ablation as the ascendant standard of care for treating this pervasive arrhythmia. Amidst a

Can AI Close the Women's Health Data Gap?
Patient Care Can AI Close the Women's Health Data Gap?

For decades, the field of women's hormonal health has been characterized by a pervasive trial-and-error approach, leaving millions grappling with complex conditions from contraception to menopause with imprecise guidance. The historical underrepresentation of women in medical research has created a

CMS Proposes Major Overhaul of ACA Insurance Marketplace
Regulatory & Compliance CMS Proposes Major Overhaul of ACA Insurance Marketplace

With the healthcare landscape in constant flux, the latest proposal from the Centers for Medicare & Medicaid Services aims to reshape the Affordable Care Act marketplaces. To help us understand these sweeping changes, we're speaking with James Maitland, a leading expert on U.S. health insurance

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later